News

Coronary artery calcium may be a predictor for all-cause mortality, including non-cardiac conditions

09 Nov: Coronary artery calcium may be a predictor for all-cause mortality, including non-cardiac conditions

In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only significantly less likely to die from heart conditions—including heart attacks and heart failure—but also are at reduced risk of death from

PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

09 Nov: PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

Credit: Pixabay/CC0 Public Domain Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions

Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

09 Nov: Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

Credit: Unsplash/CC0 Public Domain Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only the culprit artery causing the heart attack according to a new, large international study led

ENCIRCLE trial transforms treatment of mitral regurgitation

29 Oct: ENCIRCLE trial transforms treatment of mitral regurgitation

Credit: Pixabay/CC0 Public Domain David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter’s Advanced Heart & Vascular Service Line, presented results of the international ENCIRCLE clinical trial at the Transcatheter Cardiovascular Therapeutics conference in San Francisco, Calif. The findings were simultaneously published in The Lancet